eli lilly tirzepatide patent BPI challenges Lilly's : r/tirzepatidecompound eli lilly tirzepatide patent expiration

With the emergence of an oral tablet alongside a once-weekly injectable Wegovy, patients may ask, Which option is better for me? While both target similar pathways, the decision is less about better and more about fit

As we expect supply to be constrained for the foreseeable future, a proportion of available supply will be allocated for use only within the NHS to allow healthcare professionals to implement NICE guidance

Evidence includes medical records and drug usage history

While there have been some supply issues to heavy demand, these are expected to ease

A 4% incidence of anemia after one year on GLP-1 RAs was noted, which is roughly 1 in 25 patients

Ironically, it was the United Kingdom and not the USA that led the way to approving higher dosage levels of semaglutide up to 7.2 mg per week